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In vitro protein digestibility tests
A B S T R A C T
The current allergenicity assessment of novel proteins is based on the EFSA GMO guidance. Recently, EFSA
launched a new guidance document on allergenicity assessment of GM plants (2017). This document describes,
amongst other topics, the new scientific and regulatory developments on in vitro protein digestibility tests. The
EFSA GMO Panel stated that for in vitro protein digestibility tests, additional investigations are needed before
any additional recommendation in the form of guidance can be provided. To this end, an interim phase is
considered necessary to evaluate the revisions to the in vitro gastrointestinal digestion test, proposed by EFSA.
This prompted the establishment of a joint workshop through two COST Action networks: COST Action
ImpARAS and COST Acton INFOGEST. In 2017, a workshop was organised to discuss the relevance of digestion
in allergenicity risk assessment and how to potentially improve the current methods and readouts. The outcome
of the workshop is that there is no rationale for a clear readout that is predictive for allergenicity and we suggest
to omit the digestion test from the allergenicity assessment strategy for now, and put an effort into filling the
knowledge gaps as summarized in this paper first.
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The global food industry has a challenge to provide food for 9 bil-
lion people, at a sustainable level, by 2050, in the context of an in-
creasing shortage of protein sources from known and traditional foods.
By introducing novel protein sources, consumers will encounter new
proteins, some of which may act as food allergens and thus significantly
increase the probability of food allergy.
Food allergy is one of the most prevalent disorders in the Western
world, with a prevalence around 5–8% in young children and 2–4% in
adults (Sicherer and Sampson, 2014). Although severe, fatal reactions
are rare, they are also very unpredictable. This results in a significant
adverse impact on the quality of life of allergic individuals and their
families, due to the potential for serious, potentially life-threatening
allergic reactions (anaphylaxis). Food allergy has a substantial eco-
nomic impact that directly impacts on society (e.g., medical care,
dietary provision etc.) and indirectly due to illness, time and money
spent for non-allergenic food purchase, etc. Also, the food industry
regularly faces the financial and reputational consequences of food
incidents and recalls, for instance, due to food allergen cross-con-
tamination during production.
The food industry is tasked with (under national/pan-national reg-
ulations) the provision of safe food. Significant cost savings and im-
proved resource utilization can be achieved when allergenic risk is
predicted early in the development process of (novel) food proteins.
However, the components of such a risk assessment have not yet been
fully developed. The interplay between different factors, such as protein
characteristics, mechanisms underlying allergic sensitization and in-
dividual risk factors remains unclear and validated predictive methods
are lacking. The need for an allergen risk assessment for novel foods is
set in the European legislation (EU-2015/2283). The allergenicity as-
sessment suggested is based on EFSA GMO (Genetically Modified
Organisms) guidance: “Allergenicity assessment of GM plants” pub-
lished in 2011 and Implementing Regulation EU (No) 503/2013 (EFSA,
2011). Recently, EFSA launched a guidance document on allergenicity
assessment of GM plants (Naegeli et al., 2017), which supplements the
aforementioned guidance document. This new guidance document de-
scribes, amongst other topics, new scientific and regulatory develop-
ments on in vitro protein digestibility tests and suggested as an addi-
tional recommendation for a digestion test more investigation is
needed. Therefore, an interim phase has been implemented to in-
vestigate the applicability and scientific relevance of the digestion test
in allergenicity assessment.
This context was a perfect occasion for COST Actions ImpARAS and
INFOGEST to join forces. COST Actions are bottom-up, pan-European
research networks funded by the various research and innovation fra-
mework programmes, such as Horizon 2020. The Improved
Allergenicity Risk Assessment Strategy COST Action (ImpARAS,
FA1402, www.imparas.eu) focusses on identifying gaps and generating
new ideas and plans for improving the allergenicity assessment
strategy. The COST Action INFOGEST stands for “Improving Health
Properties of Foods by Sharing our Knowledge on the Digestive Process”
and aimed to improve the current scientific knowledge on how foods
are disintegrated during digestion and successfully promoted and im-
plemented a harmonized digestion model (FA1005, www.
cost-INFOGEST.eu/). In April 2017, a joint workshop was dedicated
to the topic of the relevance of digestion in allergenicity risk assessment
and how to improve the current methods and readouts. The outcome of
the workshop is summarized in this paper including current knowledge,
identified gaps and suggestions for future research.
Throughout the document we use the terms allergenicity, allergenic
potential and immunogenicity. The definitions are defined as: i) aller-
genicity or allergenic potential: the potential of a material to cause
sensitization and allergic reactions, frequently associated with IgE an-
tibody and ii) immunogenicity: the ability of a material to elicit an
immune response.
1.1. Current approach
The allergenicity risk assessment of novel proteins is mainly based
on the guidelines mandated for GMOs using a weight-of-evidence ap-
proach, which involves an integrated case-by-case strategy. The safety
evaluation incorporates as its main focal elements consideration of: the
origin of the gene; sequence homology of the new encoded protein with
known allergens; binding of the new protein by IgE from allergic in-
dividuals; and stability of the protein in a pepsin resistance test. No
clear protocol for the pepsin resistance test is provided in the guide-
lines, thus many applicants use the method described by Astwood et al.
(1996) or derivatives thereof, such as the protocol of Thomas et al.
(2004) as that one has been adopted more widely in industry as a
harmonized approach to the assay. However, this method has never
been rigorously validated and there is still controversy regarding the
potential link between the ability of a protein to resist the digestive
process and its ability to induce an immune response. Presumably, it is
not necessary for a protein to be intact when reaching the epithelial
cells for this to happen. Fragments generated during digestion are fre-
quently long enough to include at least 2 epitopes (i.e., with a mole-
cular weight of 3.5 kDa) to cause sensitization (Lack et al., 2002; Mills
et al., 2004). In a pioneering study, Astwood et al. used a rather crude
incubation test with pepsin and compared the resistance to pepsin di-
gestion of 16 known food allergens (e.g., ovalbumin (OVA)), β-lacto-
globulin, Ara h2, β-conglycinin) and 9 common plant proteins con-
sidered to be non-allergenic (e.g., Rubisco Large Sub Unit and Small
Sub Unit from spinach leaf, lipoxygenase from soybean seed, sucrose
synthetase from wheat kernel, β-amylase from barley kernel or acid
phosphatase and phosphofructokinase from potato tuber). Overall,
major food allergens resisted the digestion process in contrast to non-
allergenic proteins (mainly enzymes) that were rapidly digested
(Astwood et al., 1996). In another study, impairment of the digestion
process was shown to increase allergenicity of parvalbumin, the major
fish allergen protein as measured by specific IgE and IgG1 levels and
skin tests in a BALB/c mouse model, supporting the hypothesis that
there is a link between resistance to digestion and allergenicity
(Untersmayr et al., 2003). These results were later confirmed in human
adults (Untersmayr et al., 2005a). However, when reviewing published
literature on the digestion of pure allergens, Bøgh and Madsen did not
find clear evidence of this link among a wider range of proteins (Bøgh
and Madsen, 2016). Actually, the assessment of the allergenicity of
digestion products, by either IgE-binding, elicitation or sensitising ca-
pacity, showed that digestion may abolish, decrease, have no effect, or
even increase the allergenicity of food allergens. Fu et al. tested a
number of comparable allergenic and nominally non-allergenic proteins
with similar cellular functions for their ability to survive in vitro di-
gestion. They selected 23 allergens and found no clear relationship
between digestibility measured in vitro and allergenicity (Fu et al.,
2002). This absence of link between the ability of a protein to resist
digestion and allergenicity might be explained by the experimental
conditions used to digest the proteins (enzyme: substrate ratio, pH and
duration of the gastric phase, etc.) and also by differences in the ana-
lytical techniques that were used to characterise the digested product
(e.g., ELISA, mass spectrometry, basophil activation tests, etc).
In 2013, a report on protein digestion commissioned by EFSA con-
firmed the contradictions found using the pepsin digestion test and
suggestions for improvements were presented (Mills et al., 2013), as
summarized below:
1) Lack of harmonisation of in vitro digestion test conditions that makes
comparison of results difficult.
→ Needed: standardisation and optimization of digestion conditions
(e.g., clear description of the source and specific activity of the
proteases used; time course and sampling method employed; mixing
method used during digestion; inactivation of further proteolysis)
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2) No standardised method for monitoring and characterizing protein
fragments and intact protein after digestion.
→ Needed: methods to characterise large resistant fragments that are
more difficult to follow using LC-MS and standardised staining
protocols for SDS PAGE.
3) Digestion protocol (“batch” assays) cannot replicate the dynamic
digestion process that takes place in real life situations.
→ Needed: apply several analyses using pH ranges and pepsin: protein
ratios such as those found physiologically.
4) Lack of consensus on comparators and standardised proteins to be
included in digestion tests.
→ Needed: a “reference” set of allergenic and non-allergenic proteins.
5) At present digestion is not a sufficiently mature area of science to
warrant inclusion in the risk assessment process.
→ Needed: interim phase to investigate the applicability of the diges-
tion test in allergenicity assessment and to evaluate the revisions
suggested.
During the interim phase, the old guidance on digestion remains in
place (using solely pepsin digestion) and a two-year interim period was
provided to further investigate (Naegeli et al., 2017): different test
conditions to mimic digestion in healthy, impaired and elderly in-
dividuals and infants, to identify the interplay between pH, enzyme
concentration and duration of the digestion, to consider intestinal di-
gestion, and the use of a reference set of allergenic and non-allergenic
proteins. Methods should be investigated to ensure reliable and robust
digestion read-outs and end-points which enable a better comparison of
test results. In addition, a definition of transience and persistence of
digestion fragments should be defined, using concepts such as half-life.
The report suggests that persistent peptide fragments with ≥9 amino
acids in length are critical and may indicate that further assessment is
required.
Based on the discussions during the ImpARAS-INFOGEST joined
workshop, it was concluded that other factors in addition to those
stated in the EFSA document might play a role as well in protein sen-
sitization and digestion (See Fig. 1). These factors should be considered
to establish a well-defined opinion about whether digestion resistance is
relevant in an allergenicity assessment and if further optimization of the
digestion protocol is worthwhile. The workshop members proposed that
further information is needed relating to the following:
• Characteristics of the normal versus atopic population (stomach
pH, enzyme concentrations) which may affect digestion of proteins.
• Barrier function and sensitization routes may be essential to
determine if other routes of sensitization (e.g., skin, lung) are re-
levant in food allergy, which bypasses GI digestion.
• influence of pH on digestion and the factors that may impact this
pH such as other diseases and medicine use which may influence
gastric acid secretion as well as production of intestinal digestive
juices and stomach and gastrointestinal pH.
• The role of brush border membrane enzymes in the digestion of
proteins and peptide fragments focusing on luminal digestion pro-
ducts that can be further degraded by these enzymes, and may then
be activated/inactivated before reaching the immune system.
• Involvement of antigen presenting cells (APC) in the digestion
process. APC digest proteins internally with endolysosomal enzymes
before presenting to antigen-specific T cells, suggesting that en-
dolysosomal digestion should be as important as gastrointestinal
digestion.
• How matrix and processing influence digestion intensity and ki-
netics and thus, the degradation of allergenic proteins, but also the
generation of allergenic protein fragments. In theory, processing of
an intact protein may result in different fragments to those observed
without processing. Furthermore, re-aggregation of small non-sen-
sitising fragments may occur resulting in larger entities which can
be presented by APCs.
• The relevance of dynamic vs. static digestion models to closely
mimic physiological digestion conditions.
• The importance of sensitivity and reproducibility of digestion
readouts (e.g., kinetics, fragments, bioactivity of fragments, etc.).
In the following sections, these topics will be addressed in more
detail.
2. How might physiological differences between atopic and non-
atopic individuals affect allergen digestion and absorption?
Allergen digestion and absorption is a complex process which is
often divided into three phases:
Oral phase: Mechanical digestion in the oral cavity is an essential
first step in increasing the potential surface area of food to enzymatic
Fig. 1. Factors influencing food digestion and sensitization to food proteins.
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action, initially to salivary amylase. The ability to chew food varies
with age; as a response, infants are fed pureed foods which do not
need to be chewed. Saliva is a mixture of components, which vary
through early childhood and may be related to the introduction of
solid foods in this age group (Manconi et al., 2013; Morzel et al.,
2011). Absorption can also occur across the buccal mucosa without
enzymatic degradation – something which has been demonstrated for
peanut – with the potential to cause an immune response (Dirks et al.,
2005). The latter study was performed in healthy, non-allergic adults.
Whether absorption is different in atopic individuals is unknown.
Saliva might also contain allergen-specific Immunoglobulin A (IgA),
an antibody which binds allergen and potentially affects its absorp-
tion. Levels of allergen-specific IgA vary with age (Bottcher et al.,
2002), although this may be confounded by allergen exposure. Of
interest, a prospective study in 79 children with family history of
atopy and 129 controls without an atopic family history found a
higher occurrence of saliva IgA deficiency in the former, although no
association was found between salivary IgA levels and the presence of
clinical disease (van Asperen et al., 1985).
Gastric phase: Suppression of gastric acidity has been reported to
be associated with increased protein absorption (Bloch et al., 1979;
Kraft et al., 1967). This has led to concerns that gastric acid sup-
pression may affect allergen denaturing (Untersmayr and Jensen-
Jarolim, 2008) and might explain epidemiological data that antacid
treatment in early childhood can increase the risk of food allergy
(Mitre et al., 2018). Gastroesophageal reflux is common in infants
with cow's milk protein allergy. However, there is a lack of data as to
whether gastric pH levels are altered in atopic individuals, or whether
the risk is purely due to iatrogenic use of medication. In support of the
latter, pepsin secretion – considered important in the digestion of
peanut allergens (Kopper et al., 2004) – appears to remain stable
throughout childhood to mid-adulthood, but then may wane in old age
(Feldman et al., 1996), yet this has not been associated with increased
food allergy in old age. Furthermore, in an adult cohort, only a small
percentage of food-allergic patients (7.7%) used antacids (Versluis
et al., 2016). However, studies on the development of adult food al-
lergy are rather scarce. Humans have a wide variation in their gastric
secretions: pepsin concentration can vary over 10,000 fold between
individuals (da Silva Gomes et al., 2003), and is further affected by the
type of food consumed. But again, no data is available regarding dif-
ferences in atopic versus non-atopic individuals.
Intestinal phase: Atopic status may affect allergen absorption
through both IgE-mediated and –independent mechanisms. The in-
cidence of non-IgE-mediated food allergy is up to 5% in infancy and
can result in impaired epithelial barrier integrity, increasing allergen
exposure and absorption. In laboratory studies, facilitated allergen
uptake through the low affinity-IgE receptor may occur (Li et al.,
2006), suggesting that sensitized atopic individuals may have dif-
ferent absorption kinetics for the allergens against which they produce
antibody (Steele et al., 2012). Gut motility and intestinal blood flow
will both affect digestion and absorption, though there are no data
that these differ with atopic status; a greater effect is likely to be seen
with everyday activities including exercise and alcohol intake, as well
as medication use. Nonetheless, recent studies have identified changes
in gut microbiota associated with food allergy status (Plunkett and
Nagler, 2017), although it is difficult to assess the impact of reverse
causality.
Hardly any information is available on physiological differences in the
oral and gastric phase between atopic and non-atopic individuals.
Already sensitized individuals may have an altered absorption kinetics
for the allergens against which they produce antibodies.
3. How does the gastrointestinal pH influence allergen digestion?
The impact of pH on in vitro or in vivo gastrointestinal protein di-
gestion of allergenic versus non-allergenic food proteins has not been
thoroughly investigated. Based on currently available scientific litera-
ture, it is evident that the pH of the different gastrointestinal com-
partments has a substantial impact on food protein digestion.
Food is exposed to varying pH conditions within the gastrointestinal
(GI) tract, which significantly influences protein denaturation, (af-
fecting protein conformation). and local enzyme activity. In the mouth,
food is macerated through chewing and comes into contact with saliva
produced by submandibular, parotid and sublingual glands. Saliva has
an average pH range of 6.2–7.6 (Marsh, 1994), although this is affected
by oral health; for example, in patients with clinically healthy gingiva,
saliva had a pH of 7.06 falling to 6.85 in patients with chronic gen-
eralized periodontitis and increasing to more alkaline pH with chronic
generalized gingivitis (Baliga et al., 2013).
After a quick oesophageal passage, the food bolus enters the sto-
mach where it is exposed to a low pH. Typical gastric pH in a fasted
state is between 1.5 and 3.0 (Dressman et al., 1990; Evans et al., 1988;
Ono et al., 2009), although this may vary from pH 1.0 to pH 8.0 even in
healthy volunteers, with short periods of high pH peaks attributed to
water intake, swallowing of saliva or reflux of duodenal content
(Bergstrom et al., 2014; Koziolek et al., 2015). No gender differences
have been reported (Dressman et al., 1990), but pH does vary with age
due to reduced gastric fluid secretion in infants under 6 months (only
10–20% of adult volumes, when normalized to body weight) and also in
older individuals (over age 65 years) compared to mid-adulthood
(Agunod et al., 1969; Feldman et al., 1996; Hosking et al., 1975). In a
recently published meta-analysis of eight different studies, the average
gastric pH in fasted infants was pH 2.8 (Kamstrup et al., 2017). Gastric
pH is higher in preterm infants (between 3.1 and 3.4), increasing to
above pH 6 after an infant milk meal (Kamstrup et al., 2017; Michalek
et al., 2011; Omari and Davidson, 2003). At least one study in healthy
preterm infants reported an even more pronounced effect of feeding,
increasing pH to pH 7 (Omari and Davidson, 2003). The food matrix
also has a significant effect on gastric pH in adults, due to its inherent
buffering capacity: gastric pH can increase up to 5.5, and then fall to pH
1.5 or below towards the end of the gastric emptying phase (Keller,
2012; Michalek et al., 2011). Disease also influences gastric acid se-
cretion: hyperparathyroidism, Zollinger-Ellison syndrome and ex-
tensive small bowel resection are associated with enhanced gastric se-
cretion (Keller, 2012; Layer et al., 1995; Seal et al., 1982). More
commonly, gastric acid hyposecretion or achlorhydria is observed in
chronic H. pylori infection, autoimmune gastritis or due to gastric re-
sections or vagotomy (Keller, 2012). However, whether patients with
these diseases are at a higher risk of food allergy is unknown.
Most studies linking the pH of gastrointestinal fluids and food pro-
tein allergenicity have, to date, focused on the gastric environment. The
use of antacid medication to treat dyspepsia will increase fasting gastric
pH > 5, even after relatively short periods of treatment (Banerjee
et al., 2010; Bohle et al., 2006; Ono et al., 2009; Prichard et al., 1985).
Given the association between antacid medication and the sensitization
to food allergens (Scholl et al., 2005; Untersmayr et al., 2003, 2005a).
Untersmayr et al. investigated the effect of different pH levels of si-
mulated gastric fluid on the digestion of food proteins. Fish and milk
protein digestion was completely inhibited upon shifting the pH of the
simulated gastric fluid to either pH 2.75 for codfish or 3.0 for milk
proteins (Untersmayr et al., 2005a, 2005b). Digestion of codfish pro-
teins at pH 1.25 was associated with a reduced IgE-binding activity in a
digestion-time dependent manner (Untersmayr et al., 2005b). With
regards to elicitation of food allergy, low pH of the simulated gastric
fluid used for digestion of codfish proteins was found to substantially
influence their ability to trigger allergic reactions, evidenced by a sig-
nificantly reduced histamine releasing activity of the digested samples
(Untersmayr et al., 2005b). These findings were confirmed by a reduced
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capacity of digested proteins to trigger clinical reactions in codfish-al-
lergic patients (Untersmayr et al., 2007). Increased pH of simulated
gastric fluids does not only mimic the intake of anti-acid medication,
but can also be used to simulate the situation of the immature infant
digestion. By SDS-PAGE and ELISA, Menard et al. (2014) assessed the
immunogenicity of milk proteins incubated in solutions of decreasing
pH, starting at pH6.5 to mimic pH in piglets (Menard et al., 2014).
Moreover, digestion resistant and immunogenic fractions of processed
milk proteins were identified after simulating infant digestion (Dupont
et al., 2010c). By comparing models for infant and adult digestion, a
higher percentage of residual immunogenic egg proteins were observed
after simulation of infant digestion (Dupont et al., 2010b).
Despite major efforts to establish a detailed record of pH in the
different compartments of the GI tract, there remain a number of
knowledge gaps, particularly with respect to intestinal pH distal to the
stomach (Table 1). A better understanding about the influence of meal
composition on pH and gastrointestinal transit time of the food bolus
will be essential to better predict protein digestibility. Whether atopic
individuals have altered pH in the different compartments of the GI
tract due to inflammatory process, altered digestive fluid production
etc. remains unknown. As has been demonstrated for H. pylori, infection
and inflammation can be associated with altered local pH, which could
influence protein degradation locally and therefore be associated with
increased uptake of immunologically intact allergens. Finally, more
work is needed to understand the impact of altered gastrointestinal pH
on the overall microbiota composition, since the latter substantially
influences immune response and oral tolerance induction (Chinthrajah
et al., 2016; Imhann et al., 2016) as well as affect degradation of food
proteins influencing their immunogenicity (Maiga et al., 2017).
Many parameters, including disease state, food matrix and medical
prescriptions, can influence the pH in the stomach and have a sub-
stantial impact on protein digestibility. It is unknown if atopic in-
dividuals have altered gastrointestinal pH levels compared to healthy
individuals. Furthermore other factors influenced by pH must be
considered (e.g. microbiota, transit time through GI tract and protein
absorption).
4. What is the role of barrier function and sensitization route?
Physical barriers form a key part of immune defences protecting the
host from a harmful environment. These barriers include the skin and
mucosal epithelial surfaces and maintain a variety of functions for ex-
cluding undesirable foreign materials. Immune cells, microbiota and
anti-microbial peptides support this barrier function. However, when a
physical barrier is disrupted, introduction of infectious, non-infectious,
and potentially allergenic proteins may occur allowing for local and
systemic invasion/immune response. The sensitization route then cor-
responds to the location where the encounter with an antigen will lead
to specific Th2 cell activation. This encounter takes place at the epi-
thelial interface of the organism with the external milieu, e.g., skin,
pulmonary tract or GI tract epithelium, and the Th2 activation occurs in
the corresponding draining lymph nodes. In this context, food allergy is
considered to occur mainly after exposure to food antigens through the
GI route.
The GI epithelium is a complex physical barrier allowing the
transport of nutrients and small molecules while barring macro-
molecules, microbes and other non-digestible/non-absorbable mate-
rials. The epithelium interacts with food proteins after modification
with gastric acids, gastric and pancreatic enzymes and brush-border
proteases, leading mainly to peptides and amino acids, which are ab-
sorbed depending on size, polarity and shape (Snoeck et al., 2005).
However, ingested food antigens can reach the epithelial GI barrier
unmodified or as large immunogenic fragments, the quantity of which
will depend on the protein (e.g., resistance to digestion), the food (e.g.,
matrix, processing, protein levels/contents), or host characteristics
(e.g., defect in digestive function), as explained in previous sections.
The epithelial cells create an effective highly regulated tight barrier
allowing selective permeability to these antigens as part of immune
tolerance (Menard et al., 2010; Watson et al., 2005). In this context,
oral tolerance is the “default” response induced towards harmless in-
gested food antigens/fragments present in GI lumen. Oral tolerance
results from an active immune process and relies on a controlled lu-
minal food antigen sampling through intestinal epithelium and on the
pro-tolerogenic intestinal mucosa environment, both necessary for the
preferential induction of regulatory T cells in the mesenteric lymph
nodes.(Adel-Patient et al., 2011; Hadis et al., 2011); (Hamad and Burks,
2017; Rezende and Weiner, 2017). This suppressive response then relies
on an intact intestinal barrier function, which can be affected by i)
microbial signals (e.g., pathogenic bacteria, lipopolysaccharides, hel-
minth infection and Helicobacter pylori-associated gastritis) (Corrado
et al., 1998; Snoeck et al., 2005), ii) the diet (e.g., high-fat diet), iii)
medication (e.g., non-steroidal anti-inflammatory drugs), iv) some
properties of luminal proteins (e.g., allergens presenting protease ac-
tivity, such as proteins from house dust mite (Grozdanovic et al., 2016;
Price et al., 2014; Tulic et al., 2016), v) aggregation state or chemical-
induced structural changes (Bernasconi et al., 2006) vi) chemical/
physical or even psychological stress. An abnormal quantity of un-
digested proteins may also result in an alarm signal at this site {Perrier
and Corthesy (2011) #71}. When the GI barrier is disrupted, there may
also be a change in intestinal permeability leading to sensitization and
allergic reactions to food proteins in predisposed individuals (Perrier
and Corthesy, 2011; Sicherer and Sampson, 2010), but it appears that
other factors may lead to food sensitization at the GI site.
Intestinal permeability measured by the lactulose/mannose test in
food-allergic individuals and those with food hypersensitivity on al-
lergen-free diets for six months was higher compared with healthy
Table 1
Oral and gastrointestinal pH levels in health and under acid-suppressive medication.
Site Average pH level Age group Fasted/fed status Health status Ref.
oral 7.06 Adults not specified healthy Baliga et al. (2013)
6.85 Adults not specified healthy Baliga et al. (2013)
7.24 adults not specified healthy Baliga et al. (2013)
stomach 1.5–3 adults fasted healthy (Dressman et al., 1990; Evans et al., 1988; Ono et al., 2009)
5> >1.5 adults fed healthy Kamstrup et al. (2017)
2.8 infants fasted healthy Kamstrup et al. (2017)
6.4 infants fed healthy (Layer et al., 1995; Seal et al., 1982)
> 5 Adults/infants fasted PPI treatment (Barbero et al., 1952; Bratten and Jones, 2009; Ono et al., 2009)
Small intestine 6.0–7.7 adults fasted healthy Koziolek et al. (2015)
5.6 adults fed healthy Fredrikzon and Olivecrona (1978)
7 infants fasted preterm Untersmayr et al. (2003)
6.5 infants fed preterm Jensen-Jarolim and Untersmayr (2008)
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controls (Ventura et al., 2006) and remained increased in asymptomatic
food allergic children on elimination diets (Jarvinen et al., 2013), al-
though contradictory results have been described (Andre et al., 1987;
Ventura et al., 2006). Increased permeability and Th2 microenviron-
ments have also been described in sensitized individuals and during the
elicitation phase of the allergic reaction. It is hypothesized that food
particles and allergens cross the epithelial barrier and activate mast
cells bound with specific IgE in sensitized individuals, which permits
allergen passage in a setting of elevated IL-4 and CD23 on intestinal
epithelial cells (Kaiserlian et al., 1993) that bind IgE-antigen complexes
(Belut et al., 1980) and enhance transport. In allergic individuals,
chymases, histamine, TNF-α, IL-13 and IL-8 from mast cells appear to
regulate epithelial cell permeability and cause allergen molecule
transport through the barrier (Clayburgh et al., 2006; Wang et al.,
2005). Inflammatory mediators (e.g., cytokines, proteases) lead to
further disintegration of barrier function and increased passage of al-
lergens (Perrier and Corthesy, 2011). These events may lead to local
and systemic symptoms in sensitized individuals exposed to the sensi-
tising proteins, but may also lead to de novo-sensitization to intact
proteins present in the same microenvironment (i.e., co-ingested pro-
teins). However, despite data supporting increased permeability to
large molecules in allergic children (Heyman et al., 1988), it is not
entirely clear whether large protein allergens can pass through the
barrier and cause allergic sensitization. More studies are needed to
determine whether increased GI permeability is a risk factor for food
allergy in certain atopic patients because intestinal permeability para-
meters are not predictive of food allergy (Perrier and Corthesy, 2011).
Additionally, non-GI sensitization to food allergens may occur. The
ALSPAC birth cohort, a retrospective analysis, revealed that 5-year old
peanut allergic children had severe atopic dermatitis (AD) in the first 6
months of life and 90% of the peanut allergic patients with severe AD
had been exposed to peanut oil containing emollients through their
inflamed/altered skin. These findings suggest that sensitization might
occur to food antigens through the disrupted skin barrier in the absence
of oral tolerance induction through GI tract exposure (Lack et al.,
2003). Moreover, the risk of peanut allergy was positively associated
with the level of peanut allergens in the environment, notably in case of
severe AD (Brough et al., 2013, 2015). Previous studies demonstrated
that milk, egg and fish proteins were also detectable in domestic dusts
(Dybendal and Elsayed, 1994; Witteman et al., 1995). An additional
argument for cutaneous sensitization to peanut is that circulating
peanut-specific T cells from peanut allergic patients express cutaneous
homing receptors (Chan et al., 2012; DeLong et al., 2011), whereas T
cells from peanut-tolerant children express intestinal and cutaneous
homing receptors (Chan et al., 2012).
Various human and animal studies demonstrate that altered skin
permeability and/or skin inflammation increases the risk of sensitiza-
tion to foods. AD is a risk factor for food allergy and pre-school AD is
positively associated with IgE sensitization to foods and aeroallergens
up to 16 years of age (Johansson et al., 2017). Furthermore, neonatal
skin barrier dysfunction (assessed by trans epidermal water loss) pre-
dicts food allergy at 2 years of age, which supports transcutaneous al-
lergen sensitization, even in infants without AD (Kelleher et al., 2016).
Thus, a disrupted skin barrier even without symptoms may lead to
sensitization and food allergy. Sensitization through the cutaneous
route leading to a loss of oral tolerance underlies a new subtype of
wheat-dependent exercise-induced anaphylaxis in adult Japanese
women following sensitization through the use of soap containing hy-
drolysed wheat protein (Chinuki and Morita, 2012; Yagami et al.,
2017). There are many associations between genetic skin barrier defi-
ciencies and food allergy, such as the filaggrin gene mutation (Brough
et al., 2014; Brown et al., 2011; Kelleher et al., 2015; Venkataraman
et al., 2014), serine protease inhibitor SPINK5 gene variants (Ashley
et al., 2017) or corneodesmosin mutations (Israeli et al., 2011; Oji et al.,
2010).
IgE-dependent food allergy can be induced using various intact food
antigens (e.g., OVA, peanut, tree nut, cashew, milk, wheat) in animals
sensitized through skin exposure and then elicited through oral chal-
lenges. In these models, a high IgE level is induced after skin disruption
and local inflammation induced by tape stripping (Bartnikas et al.,
2013; Kondo et al., 1998; Noti et al., 2014; Strid et al., 2004), or after
application on skin with constitutive barrier defect (e.g., filaggrin mu-
tations (Fallon et al., 2009; Kawasaki et al., 2012), or using occlusive
patches (Birmingham et al., 2007; Gonipeta et al., 2009, 2010), de-
tergents (4% SDS (Muto et al., 2014),) or TSLP-inducers (Vitamin D
analog) (Noti et al., 2014). The underlying mechanisms involve local IL-
4 production by TSLP-elicited basophils, leading to Th2 polarization.
Sensitization through skin can lead to a partial loss or prevention of oral
tolerance induction (Strid et al., 2004), or no change at all (Muto et al.,
2014). In most studies, sensitization was not observed when the barrier
was unaltered. However, other studies showed that peanut or milk al-
lergen exposure on healthy skin could lead to Th2 cell priming, which
suggests that sensitization may occur through the GI route without a
Th2 mucosal adjuvant. However, this appears to depend on the food
matrix and allergen (Wavrin et al., 2014, 2015). Sensitization may also
occur through exposure via the respiratory tract to various inhaled food
proteins (e.g., wheat, shellfish, soy, peanut, egg, milk) at farms, res-
taurants, school, home or food industries (Ramirez and Bahna, 2009;
Taylor et al., 2000). There are cases of sensitization via the respiratory
route leading to food allergy, for example, a patient with an occupa-
tional inhalant pork allergy developed food allergy to pork and chicken
(Hilger et al., 2010). In mice, Wavrin et al. observed more intense and
frequent IgG1 and Th2 cell priming after respiratory exposure through
non-altered epithelium than after skin exposure (Wavrin et al., 2014).
This raises the possibility that exposure to environmental food allergens
through altered or inflamed respiratory epithelia along with tobacco
smoke, diesel particles, aeroallergen proteases, viruses and endotoxins
might lead to food allergy. Sensitization via the respiratory tract or skin
may result from allergens with particular physicochemical properties
such as conformation, polarity and ability to cross the epithelial barrier
that are independent of GI digestion. However, protein size may not be
the key determinant as shown in studies testing the sensitization po-
tency of bovine beta-lactoglobulin (18 kDa) and Ara h 1 (63 kDa) via
skin or respiratory routes (Wavrin et al., 2014, 2015). Additional
properties include the capacity to aerosolise, e.g., in steam upon
heating, coating with particles or dust may enhance the interaction
with the respiratory tract and resistance to acidic skin conditions (in
skin sensitization) and the persistence of allergens on various surfaces.
Barrier function plays an important role in IgE-mediated food sensi-
tization. While integrity of the GI epithelium is clearly critical, other
barriers play an important role, particularly in early childhood, and
therefore should be included in allergenicity assessment of novel foods.
5. What is the role of brush border membranes (BBM) enzymes
The internal surface of the small intestine is carpeted by villi, which
are lined by a monolayer of columnar epithelial cells, mostly en-
terocytes. The apical surface of the enterocytes is constituted by a dense
array of microvilli microscopically observable as the brush border
membranes (BBM). The BBM contains dozens of hydrolytic enzymes
embracing all the suites of digestive hydrolases, e.g., glycosidases, li-
pases and at least 20 different exo- and endo-peptidases with different
activities and specificities (Picariello and Addeo, 2016; Woodley,
1994). The BBM peptidases are membrane-bound (glyco)proteins fa-
cing outward from the epithelium into the intestinal lumen and can also
be released in vesicles budding from the membrane into the periapical
space of enterocytes (Hooton et al., 2015). BBM hydrolases, either
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anchored in the membrane or in vesicles, are responsible for a key step
of the final degradation of nutrients in the pre-absorptive phase. BBM
peptidases are essential to process the oligopeptides resulting from the
upstream digestion step and may be crucial in preventing the inter-
nalization of potentially harmful “non-self” polypeptides. Furthermore,
both as free enzymes and in BBM vesicles, hydrolases are active in the
intestinal lumen and are involved in complete protein digestion by di-
rect action on chyme or by activating pancreatic zymogens.
The ability of BBM peptidases to degrade or progressively hydrolyse
peptides generated by GI digestion has been clearly demonstrated for a
number of substrates, including peptides arising from gastro-pancreatic
digestion of wheat (Shan et al., 2002), peanut proteins, caseins
(Boutrou et al., 2008; Picariello et al., 2015) and ovalbumin (Claude
et al., 2019).
Exopeptidases, which are the most represented and most active
among the BBM peptidases, erode progressively peptides by cleaving off
the external residues at both ends of the chain (N or C terminal), except
when the terminal amino acid is a proline. At least three different en-
dopeptidases split large polypeptides into smaller sequences, which are
further degraded during a phase of secondary proteolysis. The primary
role of BBM enzymes is to produce absorbable amino acids or di-/tri-
peptides, which can be further hydrolysed by enterocyte intracellular
peptidases, at the same time limiting the uptake of potential im-
munogenic peptides to prevent the activation of the immune system.
Active BBM peptidases are expressed at the level of duodenum, jejunum
and ileum, though most of the peptide absorption occurs at the level of
the jejunum, which indicates that food-derived peptides released by any
digestion step are exposed to BBM enzymes prior to or during absorp-
tion in the GI tract. BBM peptidases are particularly active on sequences
up to 20–25 amino acid residues. However, also combined with residual
duodenal enzymes, they exhibit endoprotease activity and can cleave
off even entire caseins or gliadins, though much more slowly when
compared to low-sized polypeptides (Woodley, 1994, 2009).
Due to intrinsic structural stability or to process-induced modifica-
tions altering digestibility, some food-derived peptides might escape
BBM hydrolysis and, in principle, might translocate unaffected across
the epithelial barrier. Thus, immunologically active peptides can reach
and interact with the intestinal immune system, either in the sensiti-
zation or elicitation phases of food allergy. The immaturity of the di-
gestive system and the increased intestinal permeability during early
infancy might result in a relatively high uptake of immunologically
active polypeptides, perhaps underlying a contribution in sensitization.
Little information is available on the role of BBM enzymes on the
allergenic potential of a protein. Only few workflows of in vitro diges-
tion have included a step simulating BBM degradation. However, there
are relevant results in experiments aimed at identifying protein frag-
ments highly resistant to digestion in prolonged digestion models or
over-digested food systems (Hausch et al., 2002; Shan et al., 2002).
Although the immune pathogenesis of celiac disease differs from food
allergies, there appears to be a critical role of BBM enzymes with food-
derived peptides that contact the intestinal immune-competent system.
For example, the immune dominant 33-mer fragment of α2-gliadin and
similar gluten-derived peptides eliciting celiac disease are resistant to
rat and human BBM hydrolysis (Hausch et al., 2002; Shan et al., 2002).
Similarly, the susceptibility to BBM enzymes in in vitro digestion models
has implicated a molecular basis of the reduced celiacogenic potential
of diploid einkorn (Triticum monococcum) compared to tetra- and hex-
aploid wheat (Gianfrani et al., 2015). In the case of OVA, its ability to
induce the degranulation of a humanised rat basophil leukemia (RBL)
cell line activated with allergic patients’ sera varies according to its
state of aggregation. Degranulation in response to native OVA slightly
decreases during the gastric phase, but is mostly abolished after duo-
denal digestion with no further change induced by BBM digestion
(Claude et al., 2019). In contrast, OVA aggregates exhibit a low de-
granulation capacity in all stages of digestion. Adding a BBM enzyme
digestion step did not substantially change degranulation capacity of
OVA aggregates, suggesting that the peptide sequences causing de-
granulation were most likely already degraded by duodenal enzymes.
(Claude et al., 2019). No digestion studies were found using BBM en-
zymes to distinguish non-allergenic vs. allergenic food proteins.
The contact of epitopes with immunocompetent cells such as DCs
might occur in the intestinal lumen, before BBM enzymes degrade
polypeptides. However recent studies appear to confirm that food al-
lergens must cross the gut epithelium, at least, in the elicitation phase
(Chinthrajah et al., 2016). Taken together, these data indicate that food
protein digestibility and allergenic potential must be assessed with BBM
enzymes during peptide digestion. Thus, simulating digestion with BBM
hydrolases should be included in models of digestion simulating the
entire digestive process, though an experimentally established con-
sensus on the use of BBM enzymes is lacking due to a series of factors
(Hooton et al., 2015; Picariello and Addeo, 2016) including the fol-
lowing:
- More information on the activity of the different peptidases is
needed.
- Enzyme activity should be determined using validated methods,
which are currently lacking.
- Intra- and inter-individual variability of the peptidase activity
makes comparison between studies difficult.
- The enzymatic activity of BBM enzymes significantly varies along
the different segments of the small intestine, while food-deriving
material is progressively adsorbed. Estimating a physiological re-
levant peptidases-to-food substrate ratio is challenging.
- BBM enzymes are not commercially available and are laborious to
purify.
- Representative and standardised enzymatic preparations are
needed.
- More studies are needed to compare activity of pig, mouse and
human BBM enzymes.
- Information on physiologically relevant conditions to use BBM en-
zymes in models of simulated digestion is necessary, because con-
ditions adopted in previous papers appear without justification
(Boutrou et al., 2008; Hausch et al., 2002; Petrilli et al., 1984; Shan
et al., 2002).
- An overall clear role of BBM enzymes in the allergic response of
proteins must be elucidated
Simulating digestion with BBM hydrolases should be included in
models of digestion simulating the entire digestive process, though an
experimentally established evidenced based consensus on the use of
BBM enzymes is lacking.
6. What is the involvement of antigen presenting cells in the
digestion process?
Antigen presentation by APC is a critical regulator of adaptive im-
munity (see Fig. 2). APC take up food proteins, process them and pre-
sent the resulting peptide fragments in the context of MHC II molecules
to T lymphocytes. Processing and degradation of antigens in specialized
cellular compartments such as endosomes and lysosomes are essential
for many aspects of antigen presentation (reviewed in (Roche and
Furuta, 2015)). This degradation process is tightly regulated and in-
volves activation of different proteases (e.g., cathepsin S and aspar-
aginyl endopeptidase) which in turn promote the peptide MHC II
complex assembly. Susceptibility of proteins to lysosomal proteolysis
plays an important role in determining their immunogenicity (Thai
et al., 2004; Toda et al., 2011). There seems to be a highly regulated
balance between antigenic protein proteolysis and complete
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degradation of proteins and destruction of peptides bound to MHC II in
the antigen processing compartment of the APC. The stability to en-
dolysosomal proteolysis leads to low-density of MHC II-peptide com-
plexes on DCs which favours Th2 responses (Buatois et al., 2003;
Delamarre et al., 2003). Indeed, efficient Th2 cell activation requires
high stability in the early endosome, but efficient degradation in a
lower pH environment in the late endolysosomal compartment
(Machado et al., 2016). However, both extremes, e.g., very high and
very low protein stability to proteolysis seems to result in inadequate
quantities of T cell peptides needed for efficient antigen presentation.
In vitro assays determining endolysosomal degradation may be an
efficient tool providing information on the immunogenicity or aller-
genicity of proteins and information about peptide clusters harbouring
T cell epitopes. In allergy research, two assays have been used to si-
mulate antigen processing in the lysosomal/endolysosomal compart-
ment upon uptake by professional APC (Delamarre et al., 2005, 2006;
Egger et al., 2011). The first method involves the coupling of proteins to
latex beads, which allows for tracking of intracellular, phago-lysosomal
protein degradation over time in APC by flow cytometry (Hoffmann
et al., 2012; Savina et al., 2010). This method correlates with phago-
somal functions, antigen degradation and APC processing and loading.
This method was used to assess and compare degradation of several
food allergens, including OVA, peanut Ara h 1, Ara h 2, Ara h 3 and Ara
h 6 and ß-lactoglobulin. Intracellular protein degradation was higher
for Ara h 1 and Ara h 3 than for Ara h 2 and 6, which might correlate
with the magnitude of T cell activation by these allergens (Smit and
Pieters, 2017). In addition, modification of ß-lactoglobulin by glycation
changed intracellular degradation, which most likely caused this pro-
tein to be more available for proteolysis, leading to decreased im-
munogenicity (Perusko et al., 2018). The second method is used more
often than the first and focuses on the fractions containing en-
dolysosomal proteases from APC. The DC line, JAWS II, as well as
mouse bone marrow- and human blood-derived DCs are most fre-
quently used because of a high similarity in composition and proteolytic
activity of isolated endolysosomal fractions (Egger et al., 2011). How-
ever, proteolytic activity differs between proteases from different cell
types, with highest protease efficiency in macrophages > DCs > B
cells, though, highly similar peptide profiles were observed despite
kinetics differences (Hofer et al., 2017; Roche and Furuta, 2015). Ty-
pically, proteins are incubated with lysosomal fractions at 37 °C at low
pH which simulates the endolysosomal environment and degradation
kinetics is monitored by gel electrophoresis and proteolytic peptides are
analysed by mass spectrometry. The lysosomal fractions contain several
endo- and exo-proteases like cathepsins and legumins, which are cap-
able of enzymatically processing the intact protein. A major role is at-
tributed to cathepsin S (Egger et al., 2011; Pablos et al., 2018). The
importance of cathepsin S was shown by specific inhibition during
endolysosomal degradation, which resulted in a drastic reduction of
proteolytic activity and peptide generation (Wildner et al., 2017). A key
feature of endolysosomal degradation is the identification of peptide
clusters containing important T cell epitopes (Gadermaier et al., 2011;
Mutschlechner et al., 2010; Schulten et al., 2011). Thus, in vitro ap-
proaches may help to downscale the number of synthetic peptides for T
cell assays, thereby minimizing the use of material from patients. This
assay was used to study the degradation of several food proteins, which
correlated with immunogenicity and allergenicity. For instance, a hy-
poallergenic variant of peach Pru p 3, which was susceptible for si-
mulated endolysosomal degradation displayed low in vivo im-
munogenicity and low IgE reactivity (Toda et al., 2011). However when
comparing allergenic lipid transfer proteins, Pru p 3 showed higher
Fig. 2. Model of endo-lysosomal allergen processing and presentation. Allergens are captured by the APC by receptor-mediated uptake, followed by transport into the
cell in endosomes. ER derived lysosomes containing MHCII αβ dimers coupled to the invariant chain (Li-MHCII) merge with this endosome to form the endo-
lysosome. In this cellular compartment, Li is proteolytically removed from MHCII, leaving class II-associated invariant chain peptide (CLIP) at the binding groove of
MHCII, which is enzymatically removed, facilitating peptide binding onto MHCII. In addition, at a lowered pH, allergens are proteolytically degraded into peptides,
which can bind MHCII. These peptide-MHCII complexes are transported to the cellular membrane by transport vesicles where they can lead to MHCII presentation to
T cells. In the endo-lysosome, sufficient proteolysis of allergens leads to peptide binding to MHCII and antigen presentation (1). If allergens are quickly totally
degraded (2), or resistant to proteolysis (3), no or insufficient antigen presentation occurs
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stability in the endolysosomal degradation assay than comparators Api
g 2 and Art v 3, accompanied by a constant supply of relevant peptides
(Gadermaier et al., 2011). Furthermore, in all studies, previously
identified immunodominant T cell epitopes of Pru p 3, were represented
within obtained peptide clusters (Schulten et al., 2009). Immunization
with native Ara h 6 from peanut induced only limited IgG levels and
presented high resistance to in vitro cathepsin digestion compared to the
immunogenic heat-treated proteins, which showed lower stability
(Guillon et al., 2016). Lipid binding led to a stabilizing effect during
endolysosomal degradation of Ara h 1 from peanut, Sin a 2 and Sin a 3
from mustard and authors suggest this might contribute to their potent
allergenic capacity (Angelina et al., 2016). Comparative analyses of
allergenic and non-allergenic molecules of the 2S albumin, tropomyosin
and collagen protein family indicated a slightly higher stability of non-
allergenic representatives (personal communication G. Gadermaier).
There are several knowledge gaps associated with the extent of al-
lergen endolysosomal degradation and the methods to study it. For
example, studying allergen endolysosomal degradation reflects sensi-
tization at the T cell level, but it does not provide information for direct
predictions about protein-IgE binding. Both methods are useful tools for
studying the intracellular processing of allergens and estimating protein
immunogenicity or allergenicity (Egger et al., 2011; Perusko et al.,
2018). However, because endolysosomal degradation is performed with
purified molecules, the influence of lipid or small molecule binding is
unknown and requires further investigation. Furthermore, the context
for allergen uptake and presentation might also play a role in the ob-
served outcome of immunogenicity. Additionally, organ-specific pre-
processing in the lung, skin or gut has not been considered. Assuming
that sensitization to food allergens takes place in the GI tract, enzymatic
digestion prior to endolysosomal processing should be considered.
In vitro assays determining endolysosomal degradation may be an
efficient tool to provide information on the process leading to im-
munogenicity and allergenicity of proteins. However, available
methods are until now proven to be particularly valuable for com-
parisons of protein isoforms, modified variants, and different batches.
Additional standardized tests in line with in vivo models should be
performed to improve the ability to predict the allergenicity of a pro-
tein.
7. What is the influence of the food matrix and processing on
digestion?
The structure of food and its processing can significantly impact
digestion kinetics (Parada and Aguilera, 2007) and can have an impact
on food protein allergenicity. For example, there are reports that show
that susceptibility to digestion, a measure of protein stability, relates to
allergenic potential (Bøgh and Madsen, 2016). Despite the debate on
this subject, the pepsin resistance test proposed by Astwood et al.
(1996) has been widely used on pure proteins, without taken the effect
of the food matrix and processing in to account. This is probably due to
the complexity of interpreting the data generated with complex mix-
tures. However, as evidence emerges on the effect of different types of
processing on various measures of allergenic potential, typically some
form of immunoreactivity such as IgE binding, it is becoming clear that
there are many factors at play. These include exposure and routes of
sensitization as well as the type of food and the way that it is processed.
We do not eat protein, we eat food and that means that the food matrix
is always highly relevant. Recent examples of this notion are studies
looking at the cellular entrapment of nutrients in raw or cooked tree
nuts, showing that a significant proportion of the nutrients are never
released and consequently pass through the GI tract without being
absorbed (Grundy et al., 2015).
Foods are often subjected to different kinds of processing before
being consumed. Simple peeling of the apple can lower exposure to
allergens when consumed, as there are high allergen concentrations in
the skin. Heating proteins, for example, can cause them to unfold and
lose secondary and tertiary structure. This in turn may lead to an in-
crease in surface hydrophobicity that is sufficient to drive aggregation.
Unfolding and loss of structure can increase the accessibility of pro-
teases to their substrate and thus make proteins more digestible.
Excessive aggregation may also have the reverse effect depending on
the density of the aggregates. For example, the whey protein β-lacto-
globulin is resistant to pepsin in its native state but heating can sig-
nificantly increase its susceptibility to pepsin hydrolysis. However, if it
is heated in a way that large aggregates are formed such as when the pH
is close to its isoelectric point (around pH 5), then pepsin resistance is
again increased (Macierzanka et al., 2012). Enzymatic crosslinking of
heat denaturated β-lactoglobulin can increase sensitising power even
though it might lower elicitation (Stojadinovic et al., 2014). The extent
to which thermal processing affects allergenic potential depends upon
the protein in question. Some proteins such as caseins or Bet v 1
homologues are only weakly folded, whereas others such as the lipid
transfer proteins (LTPs) have a more rigid structure. The former group
are heat-resistant but are easily digested while the latter group are more
resistant, yet both groups can be allergenic. Heating of the Bet v 1
homologue from apple, Mal d 1, significantly lowered IgE binding ca-
pacity although T-cell reactivity was increased (Bohle et al., 2006) and
yet the apple LTP, Mal d 3, is highly resistant to thermal processing
(Sancho et al., 2005). The effect of thermal processing (raw vs. roasting
or boiling) on peanut allergens has been widely investigated. The re-
sults show that the IgE-binding capacity of purified Ara h 1 and Ara h 2/
6 was altered by heat treatment (Blanc et al., 2011; Vissers et al., 2011).
However, no significant difference in IgE immunoreactivity of Ara h 2/
6 was observed between whole protein extracts from raw and roasted
peanuts suggesting that native IgE-reactive protein is still present in the
seed despite thermal treatment (Vissers et al., 2011). A decrease in
allergenicity of boiled peanuts resulted mainly from a transfer of low-
molecular-weight allergens into the water during cooking (Mondoulet
et al., 2005).
Heating is only one type of food processing, albeit the most
common. A range of other processes such as high pressure (HP), ul-
trasound, etc. have been considered as potential methods to reduce
allergenicity. HP treatment of apple (Husband et al., 2011) showed that
Mal d 1 was subject to loss of rabbit IgG reactivity as soon as the apple
tissue was disrupted, although it was remarkably resistant to both
thermal and HP processing. The other major allergen in apple, Mal d 3,
was found to be resistant to thermal processing in apple, which is in
contrast to behaviour in solution. However, the combination of HP and
heat treatment significantly reduced its IgG reactivity. The IgG re-
activity of Mal d 3 strongly correlates with a loss of secondary structure
of the protein (Johnson et al., 2010). Pectin was found to protect Mal d
3 from thermal denaturation in solution and is a possible candidate for
the protective effect of the fruit and highlights the importance of the
food matrix as discussed below. Already it is becoming clear that the
evidence is inconclusive, even for a single allergen. Only hydrolysis can
completely remove the allergenic potential of a protein (Verhoeckx
et al., 2015). Additionally, structural homology does not reliably pre-
dict the effect of processing on allergenicity, so that individual food
allergens should be tested and interactions with other proteins, fat, and
carbohydrates in the food matrix should be considered (Nowak-
Wegrzyn and Fiocchi, 2009).
Foods are composed of carbohydrates, fat, proteins and various
micronutrients, collectively designated the food matrix. The food ma-
trix may affect the kinetics of digestion of proteins. This is not least
because the buffering capacity of high protein content foods will in-
crease initial gastric pH and this will decrease pepsin activity as well as
alter GI motility through GI hormone-controlled feedback. High fat can
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have similar effects on GI motility depending on when lipid empties
into the duodenum. Different types of food matrices (cellular, baked,
emulsified, etc.) can have different effects (Mandalari et al., 2014;
Nowak-Wegrzyn and Fiocchi, 2009), which may occur over a range of
length-scales from molecular interactions such as glycation to en-
capsulation and factors affecting GI motility. Often it is not clear
whether the matrix or the processing has a role to play such as when
egg or milk allergic patients can tolerate baked foods containing the
relevant allergens. For example, Lemon-Mulé et al. (Lemon-Mule et al.,
2008) reported that 70% of children with IgE-mediated egg allergy
tolerated baked egg in the form of a muffin (heated at 176 °C for
30min). The authors state that “in the case of egg white, interactions
with the food matrix at high temperatures are important for decreasing
allergenicity”. These are similar results to those obtained in children
presenting with IgE-mediated milk allergy (Nowak-Wegrzyn et al.,
2008). In more recent work on egg allergy, cake was tolerated by 88%
of children and omelette food challenge was passed in 74% of cases.
This suggests that the food matrix was only important in a small
number of cases and that the important factor was the heating (Miceli
Sopo et al., 2016). Both factors may be important for digestion kinetics
(Mulet-Cabero et al., 2017). At the molecular scale, a study on the effect
of glycation on β-lactoglobulin, showed that high levels of glycation
decreased proteolysis and, consequently, increased IgG and IgE re-
activity of hydrolysates, regardless of the carbohydrate used. Protein
aggregation during the advanced stages of Maillard reaction had a
masking effect on protein epitopes, counteracting the negative effect of
the lower digestibility of glycated protein on its allergenicity (Corzo-
Martinez et al., 2010). On the other hand, differences in the response to
allergens embedded in different matrices may be a result of differences
in gastric residence times. A small study using fat continuous (choco-
late) or water continuous (mousse) food showed that the chocolate had
a longer residence time and caused a higher threshold (delayed re-
sponse) to an oral challenge to peanut (Mackie et al., 2012).
The progress in food allergy research has allowed us to assess risk on
a population scale and while processing and the food matrix have an
effect on digestion kinetics and allergenicity, we are a long way from
understanding the effects to the extent that we can predict the direction
and magnitude of any change in these parameters and properties.
Processing and the matrix may increase, decrease or abolish the al-
lergenic potential of food proteins, but whether this is a result of al-
tered digestibility remains to be investigated. Current evidence does not
provide any clear rules regarding how matrix and processing affect
digestion and allergenicity. The same processing of one protein can
increase allergenicity, while with another protein allergenicity is de-
creased.
8. What are the advantages of static or dynamic in vitro digestion
models?
The most physiologically-relevant way for studying food digestion is
to use human volunteers. However, clinical trials are expensive and
sometimes might be ethically questionable especially when invasive
strategies are used to collect effluents through nasogastric probes for
instance. Animal models have other drawbacks and this is why a large
variety of in vitro digestion models mimicking the human GI tract has
become very popular. Both static and dynamic in vitro digestion models
are used.
Static models consist of a series of bioreactors that mimic the phy-
sicochemical and enzymatic environment the food will meet when en-
tering different compartments of the GI tract (mouth, stomach, small
intestine). It is static because every step is fully completed after the next
one starts, thus, there is no flow of food between the different com-
partments until the step is completed. Additionally, the pH, con-
centration of digestive enzymes, bile salts, etc. are constant in the dif-
ferent compartments. Static models are easy to use, inexpensive and
reproducible. INFOGEST COST Action experts reviewed the correlation
between data from digestion models and in vivo experiments (Bohn
et al., 2017) and found that the static models predict end-point values
like glycaemic index, bio-accessibility of a limited number of nutrients
or digestion-resistant peptide, address underlying molecular mechan-
isms (Mandalari et al., 2009b) and are used to compare large series of
samples with identical conditions for screening purposes (Dupont et al.,
2010a). In animal science, static in vitro digestion models have been
shown to be reliable predictors of end-point values such as protein and
amino acid digestibility (Ekmay et al., 2017) but, to our knowledge,
have not been used for showing the persistence of large protein frag-
ments in the gastrointestinal tract that could be able to stimulate the
immune system and cause food allergy. The downside is that these
models may be oversimplified and might lack physiological relevance
and are not useful for following dynamic events in the GI tract such as
the kinetics of macronutrient hydrolysis.
Dynamic in vitro digestion models recreate the dynamic aspects of
food digestion. These systems simulate food transit within the different
compartments of the gut. The pH is regulated, digestive enzymes and
bile are injected in real time and nutrient absorption is possible in the
small intestine for some of them. INFOGEST experts confirmed that
these systems mimic human physiology when defined parameters are
available to control the digestive process (Dupont et al., 2018). How-
ever, systems available on the market might be expensive and are not
always adapted to solid foods requiring a thorough mixing of the food
to avoid plugging of the system. Most of them also require significant
amounts of food and digestion enzymes and may not be relevant for
studying the fate of purified expensive nutrients or bioactives. It is not
yet clear whether studying the dynamics of the digestion is needed for
assessing food allergy sensitization or whether end-point measurements
are sufficient. Dynamic in vitro digestion models are more appropriate
for investigating the fate of allergenic foods in the GI tract, assessing the
resistance of allergens to digestion and determining the effect of matrix
and food composition. However, for pure expensive single allergens,
preliminary studies with validated in vitro static models might provide
valuable information with the added advantage of being cheap and
providing information on the resistance of a protein to GI digestion. As
a compromise between simple, inexpensive static models and more
complex and costly dynamic systems, semi-dynamic systems that
combine a dynamic gastric step with a static intestinal step were de-
veloped. The gastric step, including a gradual pH decrease and pepsin
secretion, substantially impacts on the variability of protein digestion.
This has been clearly shown for the digestion of skim milk for example
(Egger et al., 2019)). Indeed, during the gastric phase of a static di-
gestion, the pH is set at 3.0 and is therefore close to the optimal pH of
pepsin (pH 2.0). Consequently, proteins like caseins are fully degraded
after 30min of gastric digestion with this model. In contrast, a dynamic
gastric condition decreases gradualy the stomach pH from 6.8 to 3.0 in
42min resulting in a slower breakdown of caseins and a proportion of
intact caseins are still visible after 60min of digestion. Semi-dynamic
systems combine the dynamics of the gastric digestion and are still
reasonably simple to apply. Because the GI tract is changing over life-
time, static and dynamic models mimicking the digestive systems of
specific populations have been developed such as static (Dupont et al.,
2010b; Menard et al., 2018) and dynamic (de Oliveira et al., 2016a,b;
Menard et al., 2014) models of the infant gut. Similarly, the GI tract of
the elderly has been modelled (Levi and Lesmes, 2014). However, there
are no models for disease and atopic individuals, nor models integrating
a complex microbiota and its metabolic activity.
The gradual hydrolysis of the main milk proteins present in a re-
hydrated skim milk powder was compared after in vitro digestion with
the dynamic DIDGI® digestion system developed at INRA (Menard et al.,
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2014) and the static harmonized INFOGEST method (Minekus et al.,
2014). Protein hydrolysis was analysed by gel electrophoresis (SDS-
PAGE), peptide patterns were established by mass spectrometry (MS)
and free amino acids quantified with high-pressure liquid chromato-
graphy (HPLC). Overall, protein hydrolysis had a similar qualitative
behaviour in static and dynamic digestion models (Fig. 3). In the gastric
phase, the peptide patterns were similar, correlation between peptide
patterns from static and dynamic in vitro digestion calculated for αs1-
casein achieved a factor of 0.77. Moreover, the peptide patterns ob-
tained at the gastric and intestinal endpoints with both in vitro digestion
protocols had a good approximation to in vivo results previously col-
lected on pigs (Egger et al., 2019) and were correlated with a factor of
0.71 (static) and 0.88 (dynamic). Gradual peptide generation was
comparable under both in vitro digestion conditions. However, the
formation of a coagulum and a cream layer in the gastric phase that
occurs during milk digestion in vivo, was absent in the static model due
to the absence of mixing, but was present in the dynamic model.
Therefore, dynamic in vitro digestion models should be chosen to study
kinetic processes occurring during digestion, notably for whole food
including matrix. At the intestinal endpoint, the total correlation cal-
culated over all proteins was 0.89 between static and dynamic models,
0.81 (static-in vivo), and 0.85 (dynamic-in vivo). Moreover, at the level
of free amino acids, the dynamic protocol resulted in a gradual release
of free amino acids that was closer to the in vivo situation. This ob-
servation can be explained by the gradual addition of active enzymes
during the digestion process. This appears to be the first study com-
paring experiments conducted with static and dynamic in vitro digestion
models with in vivo data and more studies are needed to investigate the
difference between the models and relevance to humans on other types
of food matrices.
Ideally, the best way to investigate digestion of allergens would be
to submit the allergen-containing food to a validated and standardised
in vitro digestion protocol. However, pH and enzyme conditions should
be adapted when allergy sensitization is linked to an impaired digestion
system (e.g., higher pH, less enzymes). This would enable a detailed
assessment of the decomposition of the proteins and the detection of
critical and even questionable allergenic peptides. Notably, dynamic or
semi-dynamic models handle possible matrix effects and the buffering
capacity of the food when mixing conditions are carefully chosen. When
such foods are not available, like in the case of pure allergens, dedicated
in vitro static models could be an alternative with the limitation of the
end-point of gastric or intestinal digestion, without providing in-
formation about the fate of the molecules during the gastric or in-
testinal step. A consensus model for allergenicity testing agreed by
experts in the field is crucial. Finally, the ongoing development of
microsystems to miniaturize the GI process might be added value for
the in vitro digestion of pure allergens because the quantities of proteins
that will be required will be extremely low. In this field, microfluidics
might speedup the development of miniaturized in vitro digestion
models (Marze et al., 2014).
Ideally, the best way to investigate digestion of allergens would be to
submit the allergen-containing food to a validated and standardized in
vitro digestion protocol, where the pH and enzyme conditions are
adapted to atopic individuals. It is not yet clear whether studying the
dynamics of the digestion is needed for assessing food allergy sensiti-
zation or whether end-point measurements are sufficient. Dynamic or
semi-dynamic models must be used when matrix effects and the buf-
fering capacity of the food must be considered.
9. What is the importance of digestion readout: intact proteins and
fragments?
Resistance to digestion in the GI tract has been considered a general
feature of ‘complete’ food allergens, because for a protein to sensitise
via the GI tract, the protein must survive as intact protein or as large
peptide fragments to be efficiently recognised by the immune system. In
1996, Astwood and colleagues concluded, that resistance to digestion is
an effective parameter for distinguishing food allergens from non-al-
lergenic proteins (Astwood et al., 1996). However, there is still no clear
definition on when to consider a protein resistant or susceptible to di-
gestion (Bøgh and Madsen, 2016) and no consensus about the im-
portance of the resistance of peptide fragments during the digestion
process. However, the length, the persistence, the abundance as well as
the rearrangement of peptide fragments during the digestion process,
may be important for potential residual allergenicity. Furthermore,
there is no clear-cut size above which peptide fragments may act as
‘complete’ allergens and below which they will not. Though a general
opinion appears to be that the lower size limit for allergenicity of
peptide fragments is around 3.5 kDa (FAO/WHO, 2001; Huby et al.,
2000; Lack et al., 2002; Poulsen and Hau, 1987) or 30–32 amino acids.
Recently, the EFSA GMO panel suggested that stable peptide fragments
≥9 amino acids might possess residual allergenic potential due to ef-
ficient peptide binding to HLA-DQ (Naegeli et al., 2017). Indeed, an
assessment of the in vitro digestibility may provide valuable insights on
the resistance of a given protein or a whole food to digestion in the GI
tract. However, the use of appropriate analysis methods for assessment
Fig. 3. Qualitative comparison of dynamic (red line), static (blue line) and in vivo pig (green line) digestion for β-casein and β-lactoglobulin. The same skim milk
powder was subjected to the three different digestion models. The resulting peptide patterns were measured by mass spectrometry and endpoints of the in vitro
digestion models were compared to the stomach (S) sample from pigs, while the intestinal endpoints were compared with pig samples from the duodenal (D) and the
last section of the small intestines (I4). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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of residual intact protein and derived fragments is essential.
Almost all studies evaluating resistance of food allergens to diges-
tion assessed the survival of intact protein, fewer studies examined the
stability of peptide fragments emerging during the digestion process
and even fewer identified the size distribution profile of the generated
peptide fragments (Bøgh and Madsen, 2016; Di Stasio et al., 2017a,
2017b). The majority of studies evaluating the resistance of proteins
and arising peptide fragments, did so by SDS-PAGE alone or in com-
bination with Western blotting methods, although other methods using
HPLC or MS have been used as well (Bøgh and Madsen, 2016).
Several studies have stressed that the choice of methods used for
detection of residual intact allergen and emerging peptide fragments
may heavily impact the experimental outcome and therefore the in-
terpretation of the results of the digestibility tests. Some methods allow
for detection of the amount of residual intact protein or stable peptide
fragments emerging from the digestion process, whereas other methods
only determine the presence or absence of proteins and peptides, with
more or less sensitivity and specificity. For example, a study in-
vestigating the digestibility of the milk allergen β-lactoglobulin,
showed that no intact β-lactoglobulin was left after digestion according
to SDS-PAGE, while HPLC analysis showed that approximately 10%
residual intact β-lactoglobulin remained (Mandalari et al., 2009b). Si-
milarly, an evaluation of the residual intact kiwi allergen Act d 2 after
digestion using SDS-PAGE revealed that no intact protein was left,
while trace amounts of residual intact protein were observed when
evaluated by HPLC (Bublin et al., 2008). This clearly indicates that the
two analytical methods for assessment of intact protein have different
detection limits and that the methods used for detection of emerging
peptide fragments may heavily impact on the experimental outcome.
For example, in a study investigating the digestion products of kiwi
allergens, stable peptide fragments were detected by Western blotting
with sera from allergic patients, but not with a Coomassie staining of
SDS-PAGE (Lucas et al., 2008). In another study, it was shown that
neither staining of SDS-PAGE nor western blotting with patient sera
resulted in the detection of any peptide fragment generated during the
digestion of the avocado allergen Prs a 1. However, stable peptide
fragments were clearly detected when using more sensitive and specific
methods such as MS in combination HPLC, skin prick test (SPT), or
inhibitory immunoblot and ELISA (Diaz-Perales et al., 2003).
Not only the type of assay, but also its precise experimental protocol
and reagents may influence the interpretation of the outcome of the
digestibility test. For instance, Thomas et al. (2004) reported that the
type of electrophoresis gel and the fixation techniques when performing
SDS-PAGE might influence the detection of stable peptide fragments.
Furthermore, in an inter-laboratory ring trial evaluating digestibility of
milk allergens, it was shown that the digestion assay was robust, but
sampling and electrophoretic methods had a significant impact on re-
producibility (Mandalari et al., 2009a). Collectively, these results stress
the importance of evaluating residual intact protein and generated
peptide fragments hereof in assays with appropriate sensitivities and
robustness, and that the use of more than one method is worthwhile. To
date, no single method is suitable for the detection of both intact pro-
teins and peptide fragments of different sizes in an effective manner,
and consequently, combinations of methods may provide more realistic
digestibility test results (Di Stasio et al., 2017b; Di Stasio et al., 2017a;
Naegeli et al., 2017). Other precautions should be considered when
preparing digestion products for protein-chemical analysis to preserve
structural integrity, because peptides tend to form specific formations
which is critical for the allergenic potential of digestion products (Bøgh
et al., 2012). Importantly, additional studies are needed for improved
recommendations of readouts for analyses of digestion products.
Thanks to the recent advances in -omics strategies, new and improved
analytic methods, which are continuously being established and will
eventually improve high-resolution analyses of digestion products.
No single method is suitable for the detection of both intact proteins
and peptide fragments of different sizes. Additional studies are needed
for improved recommendations of readouts for the analyses of diges-
tion products (intact protein, fragments and aggregates hereof).
10. What is the importance of digestion readout: bioactivity/
allergenicity?
An important aspect when evaluating the digestibility of allergenic
proteins or foods is to assess whether the digestion products may retain
allergenic potential after degradation in the GI tract. Certain food al-
lergens are highly susceptible to digestion, but their digestion products
may be allergenic (Bøgh and Madsen, 2016). This stresses the im-
portance of using biologically relevant and specific methods, in addi-
tion to classical biochemical methods to assess allergenic potential of
peptide fragments generated during digestion. Allergenic potential is
defined by three distinct features, the ability of a protein to bind IgE
antibodies, to elicit an allergic reaction and the capacity to sensitise de
novo (Aalberse, 2000). This emphasises that the allergenic potential of
digestion products should be evaluated on these different levels. Only
proteins and/or derived digestion products possessing all three features
are acknowledged as complete allergens, as defined by Aalberse (2000).
Notably, not all allergens are complete allergens, even in their intact
form. Well-recognised examples of incomplete food allergens are pro-
teins homologous to the birch pollen allergen Bet v 1, that may elicit
allergic reactions but normally do not sensitise through the GI tract due
to their high sensitivity to digestive proteases (Schimek et al., 2005).
However, the major peanut allergen Ara h 1, a very labile protein that is
easily digested to small peptide fragments, retains its ability to act as a
complete allergen after simulated GI digestion, being able to bind IgE,
elicit reaction as well as to sensitise (Bøgh et al., 2009; Eiwegger et al.,
2006). This relies on the capacity of generated peptides to reassemble
into specific structures.
Several studies have evaluated the IgE binding capacity of digestion
products generated after in vitro digestion (Bøgh and Madsen, 2016).
For food allergens, the IgE binding ability of digestion products can
easily be addressed when patient sera containing specific IgE to the
parent protein is available. The IgE binding capacity may be evaluated
by different methods, whereof immunoblotting and ELISAs are the most
common methods of choice. However, the results from these assays may
differ. For example, the IgE binding capacity of digestion products from
avocado and hazelnut was not detectable using immunoblotting, but
was measurable when using an inhibition ELISA and EAST (Diaz-
Perales et al., 2003; Vieths et al., 1999). This discrepancy could be
explained by differences in sensitivity of the methods. The evaluation of
the IgE binding capacity of food allergens after digestion has resulted in
abrogation, reduction, unchanged or even increased IgE binding capa-
city. For example, the assessment of IgE binding capacity of peanut
allergen Ara h 3 and caviar allergens demonstrated that no residual IgE
binding capacity was left after digestion (Untersmayr et al., 2003; van
Boxtel et al., 2008). In contrast, IgE binding capacity of the egg allergen
ovomucoid and of cod allergens was retained after digestion, although
reduced compared to the parent proteins (Takagi et al., 2005;
Untersmayr et al., 2005b; Urisu et al., 1999; Yamada et al., 2000). In
other studies, IgE binding capacity of grape allergen Vit v 1 and milk
allergen β-lactoglobulin showed that IgE binding capacity of the di-
gestion products was similar to the parent allergens (Selo et al., 1999;
Vassilopoulou et al., 2006), whereas IgE binding capacity of β-lacto-
globulin and kiwi allergens digestion products in another study was
increased in comparison to the parent proteins (Haddad et al., 1979;
Lucas et al., 2008). Only a few studies found a correlation between IgE
binding capacity and the size of the digestion products (Bøgh and
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Madsen, 2016). Moreover, various outcomes were seen for the same
allergens as a consequence of exact digestion and evaluation methods
used, as exemplified for β-lactoglobulin, but also based on the specifi-
city of the sera used to assessed IgE-binding capacity.
Few studies have investigated residual eliciting capacity of aller-
gens, i.e., the ability of the allergens to cross-link IgE antibodies on
effector cells after digestion. Assessing the eliciting capacity is a mea-
sure of the biological/functional relevance of digestion products gen-
erated during the digestion process and is more than just an ability to
bind IgE. Elicitation in vitro, ex vivo and in vivo methods include hu-
manised RBL assay, histamine release from human basophils (BAT) or
skin prick test (SPT) and have led to different outcomes depending on
the allergen. An abrogation of eliciting capacity after digestion was
shown for the apple allergen Mal d 1, the hazelnut allergen Cor a 1 and
the celery allergen Api g 1 which abrogate the eliciting capacity after
digestion (Schimek et al., 2005), whereas the eliciting capacity was
retained, though in a reduced manner, for the avocado allergen Prs a 1,
the cow's milk allergens β-lactoglobulin and α-casein, cod allergens and
cherry allergens (Diaz-Perales et al., 2003; Morisawa et al., 2009;
Scheurer et al., 2004; Untersmayr et al., 2005b, 2007). The digestion
products from peanut allergen Ara h 1 and the grape allergen Vit v 1
retain a similar eliciting capacity as the parent proteins (Eiwegger et al.,
2006; Vassilopoulou et al., 2006).
While evaluation of IgE binding and eliciting capacity can be un-
dertaken with human samples, sensitization studies cannot be studied
in humans for ethical reasons. Although no animal model has been
validated for use in sensitization assessment, they are regarded as good
alternatives to human, due to development of IgE responses with si-
milar specificity (Fritsche, 2009). Only few studies have evaluated the
residual sensitising capacity of digestion products. For example, the
sensitising capacity of digestion products from β-lactoglobulin, showed
that the digestion process abolished the sensitising capacity of β-lac-
toglobulin, while digestion products from the peanut allergen Ara h 1
retained sensitising capacity compared to the parent protein (Bøgh
et al., 2009, 2013). Partial hydrolysis of β-lactoglobulin only reduced
its tolerising potency that relies on induction of specific Treg cells in the
GALT, whereas it was suppressed by extensive trypsin hydrolysis. This
probably results from complete destruction of T cell epitopes during
hydrolysis and lead to ignorance by the GI immune system.
Based on current knowledge of residual allergenicity of allergens
after digestion, digestion may abrogate, reduce, leave unchanged or
even increase allergenic responses compared to the parent protein or
food. Untersmayr et al. (2005b) showed that while digestion products
may retain IgE binding capacity they may not retain eliciting capacity,
underlining that even though allergens may retain some allergenicity
after digestion, this may not necessarily tantamount to functional/
biological relevance.
Furthermore, digestion products containing peptides of sizes pre-
viously stated to be too low to be allergenic might still induce an al-
lergic response (Bøgh et al., 2009; Bøgh and Madsen, 2016; Eiwegger
et al., 2006) which suggests that small digested peptide fragments
should be evaluated. Additional studies are then needed to further
address the relevance of allergenicity assessment of digestion products
for improved recommendations for the specific assays for assessment of
IgE binding, eliciting and sensitising capacity.
Specific biological assays for the assessment of IgE binding, eliciting
and sensitising capacity of digestion products should be used to de-
termine the biological relevance of IgE binding and to detect activity of
very small amounts of small and large protein fragments after diges-
tion. This will improve our understanding of the relevance of digestion
in allergenicity assessment.
11. Discussion
Currently, stability in a pepsin resistance test is one of the main
pillars for assessing the allergenic potential of (novel) proteins, though
its predictive ability remains unknown. For this reason, EFSA an-
nounced an interim phase to investigate the applicability of the diges-
tion test in allergenicity assessments and to evaluate potential revisions
to improve the current in vitro GI digestion test. In 2017, COST Actions
Table 2
Summary of the discussion on relevance of digestion in allergenicity testing and the identified gaps.
Digestion is relevant for allergenicity testing Digestion is not relevant for allergenicity testing
What is known? • Everything goes through the mouth, digestion increases exposure and is
therefore relevant in risk assessment
• Digestion is related to sensitization through GI tract• Many stable proteins (in stomach) are causing severe allergic reactions.
The labile allergens are causing mild reactions and are mostly cross
reactive with pollen.
• When the pH in the stomach is altered (elevated), more people get
sensitized (infants, antacids)
• Poor predictability of current tests: too much focus on disappearance of
intact protein, not on appearance of allergenic/sensitising fragments.
• Processing and food matrix influence digestion• endolysosomal digestion in APC and by BBM enzymes should be
considered
• Digestion is not predictive since some known allergenic proteins are stable
while others are labile. This is also seen for non-allergenic proteins
• Fast allergic reactions are already seen when food is in the mouth of a
patient. The food did not enter the stomach yet and is thus not subjected to
proteolysis.
• Where does sensitization takes place? Other routes (skin, lung) of exposure
might play a role in food allergy.
• Barrier is important• Intact protein enters the intestinal compartment due to gastric emptying• In humans digestion is depending on many individual factors (age,
medication, food consumption habits etc.), which are not constant
throughout the life. Tests can only be predictive for the general population,
but never for an individual, due to these variations.
What are the gaps • Evidence role of elevated pH on digestion mechanism and what is the pH in the GI tract of atopic individuals?• Rational to use a certain enzyme: protein ratio and pH in digestion assay.• The role of microbiota in food allergy development/sensitization/food digestion/gastrointestinal barrier function?• The exact mechanisms of trans-epithelial and transcutaneous transport that allow passage of food allergens to migrate and interact with the immune system,
to determine whether there are differences between allergenic and non-allergenic proteins.
• Knowledge regarding site/mechanisms of sensitization (lung, skin, gastrointestinal)• The role of endolysosomal digestion, can we use it as a standalone model or should it be incorporated in a digestion strategy?• The role intestinal BBM enzyme hydrolysis in allergic responses, can we use it as a standalone model or should it be incorporated in a digestion strategy?• A better understanding about the influence of meal composition on pH levels and gastrointestinal transit time of the food bole will be essential to better
predict protein digestibility.
• Information on how processing influence digestion. Do other fragments occur or is just the kinetics changed?• Evidence that a physiological model is more predictive than static model.• Information on what should be the readout: kinetics, endpoint products, bioactivity and which methods can be used to measure these endpoints.• Information on how well peptide fragments of different sizes elicit and sensitise?• Information on how non-allergenic proteins behave and what are good reference proteins.
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ImpARAS and INFOGEST organised a workshop addressing the re-
levance and applicability of the pepsin resistance test in allergenicity
assessment of proteins and how to improve the test. The main conclu-
sions and gaps are listed in Table 2 and are summarized below.
Allergic symptoms may be experienced within seconds of exposure
to the oral mucosa (elicitation) and sensitization is possible via different
routes; respiratory, skin and oral. The contributions of these routes to
food allergy and food sensitization have not been thoroughly in-
vestigated. Allergenic proteins may cause allergy due to cross-reactivity
with pollen (e.g., Bet v 1 homologues), while others can sensitise via the
skin (e.g., peanut) or lungs (e.g., shrimp). Atopic compared to non-
atopic individuals may have different absorption kinetics for allergens
against which they produce antibody, which suggests that barrier status
might be more important than digestion. Sensitization and food allergy
may occur when the barriers are compromised and whole allergens or
their large sized fragments pass through the barrier and interact with
the immune system; this can be amplified by a variety of “extrinsic”
factors. However, it is not completely clear if an enhanced intestinal
permeability is the cause or the result of an immune-mediated adverse
reaction to foods (Price et al., 2013). While there is active research in
the area of barrier function, there remain many knowledge gaps least of
which are i) the exact mechanisms of trans-epithelial and transcuta-
neous transport that allow passage of food allergens to migrate and
interact with the immune system, ii) differences between allergenic and
non-allergenic proteins that enable preferential transport, and iii) de-
pendence on physicochemical properties that determine resistance to GI
digestion. In the context of sensitization through skin or respiratory
tract, it appears that a digestion resistance may not be informative at all
for assessing allergenic properties of food proteins.
The pH of the different GI compartments has a substantial impact on
food protein digestion. This is exemplified by changes in pH associated
with disease, use of antacids, and the effects of age with infancy or old
age contributing to the individual digestive capacity, which might
predispose to adverse reactions to food. However, it is not clear if this
occurs with allergenic proteins or all proteins. Factors other than an
altered pH (e.g., antacids) may play an important role in food allergy
and food sensitization as Versluis et al. showed that only a small per-
centage of food allergic patients (7.7%) used antacids (Versluis et al.,
2016). In addition, the GI microbiome substantially influences immune
response and oral tolerance induction (Chinthrajah et al., 2016; Imhann
et al., 2016). Recent studies have identified changes in gut microbiota
associated with food allergy (Plunkett and Nagler, 2017). However, it is
difficult to assess the impact of reverse causality. One critical factor is
the lack of reports addressing gastric pH or gastric/intestinal secretions
in atopic individuals, which is necessary for understanding the me-
chanisms underlying food allergy, which will aid the development of
the digestion assays.
In addition to GI pH, microbiota, other mechanisms in the GI tract
may have a substantial impact on how the immune system encounters
food proteins. Protein hydrolysis takes place in the GI tract due to en-
zymes produced by the brush border membranes. Many peptidases are
among these brush border enzymes, though their role in the allergic
response to proteins remains unclear they should not be neglected. For
instance, BBM enzymes may have a great impact on the size of the
proteins crossing the barrier and may improve the predictive ability of
the digestion test and should not be omitted in digestion models si-
mulating the entire digestive process. Consensus on how to use BBM
enzymes in experiments is currently lacking and needs further in-
vestigation.
APC are involved in the processing and presenting of proteins to the
immune system. Intact proteins/protein fragments are, after crossing
the barrier (GI, airway or skin) or due to direct sampling from the gut
lumen, taken up by APC and subjected to endolysosomal degradation,
which has not been extensively studied. High protein stability might to
some extent depend on the protein family and (enhanced) allergenicity.
However, a limited number of (food) allergens have been studied and
correlated to T cell reactivity and allergenicity. More studies are needed
to draw conclusions on the benefit of endolysosomal degradation as a
standalone assay or if this should be incorporated in an assay covering
the whole digestion cascade from stomach, intestinal, BBM enzyme
hydrolysis to endolysosomal degradation.
The effect of processing and matrix is important but not currently
incorporated into digestion assays despite the fact that both may affect
the allergenicity of food proteins. Whether the effect on allergenicity
occurs via altered digestibility due to pH changes in the stomach or
structural changes of the protein remains to be investigated. Processing
of one protein may increase while another decreases allergenicity,
which might be an explanation for the unpredictability of the digestion
assays. The effect of matrix and processing on allergenicity requires
more investigation and might be incorporated eventually in digestion
assays, though it will not be possible to incorporate these factors in a
simple (static) digestion models. Alternatively, in dynamic or semi-
dynamic models, possible matrix effects and the buffering capacity of
the food when mixing conditions are carefully chosen might improve
model predictability. Pure allergenic proteins can be digested using
dedicated in vitro static models, with their limitation that these models
consider the end-point of gastric or intestinal digestion, without giving
information about fate of molecules during the gastric or intestinal step
(digestion kinetics). A consensus model for allergenicity testing agreed
by experts in the field is crucial.
While a model should reflect the human situation, it is more im-
portant that it is predictive, but this is only possible when the method is
more physiologically relevant than the currently used methods. A static
pepsin digestion is not physiologically relevant and thus a more dy-
namic system that addresses factors such as matrix and kinetics is
crucial, however the usage of these models for their predictive ability in
allergenicity assessment still needs to be demonstrated. The inclusion of
BBM enzymes, transport across the barrier and endolysosomal de-
gradation might be important to further enhance the predictive ability
of the assays but will increase the complexity, the costs and thereby
reduce its usefulness as a screening assay.
Furthermore, it is important to make decisions on the readout of the
system before deciding on a digestion assay or strategy including cri-
teria for defining a protein as an allergen. Key readouts should be: re-
sidual intact protein, peptide fragments and residual allergenicity of the
formed digestion products, which should be evaluated with assays with
appropriate sensitivities and robustness, and more than one method
should be used. Before being recommended for use in allergenicity risk
assessment of food proteins, methodology for the evaluation of the di-
gestion products generated during the digestion process should be
standardised for profiling intact proteins, large peptide fragments and
small peptides. Moreover, it is vital to correlate allergenicity with other
properties such as size to improve predictive ability of allergenicity.
The EFSA opinion document (Naegeli et al., 2017) suggests the use of
the terms transient and persistent for digestion fragments based on
concepts such as half-life and that a persistent peptide fragment with
≥9 amino acids in length is critical and may indicate that further as-
sessment is required. However, all proteins will form 9 amino acids
fragments after digestion with pepsin followed by chymotrypsin and
trypsin. The quantity of 9 amino acids fragments depends on the size of
the protein. Indeed 9 amino acids fragments bind T cell epitopes, but 9
amino acids length is important for inducing allergy, and for inducing
other immunological responses (Th1 and tolerance) as well and will
therefore be difficult to use as a discriminating factor for allergenicity.
Because hydrolysis/breakdown of any protein will result in fragments
≥9 amino acids (as tested using PeptideCutter, data not shown),
whether they are allergenic or not, therefore additional tests will al-
ways be needed to discriminate between those posing a risk and others.
This suggests that digestion is not sufficiently discriminating and could
be omitted from the current allergenicity risk assessment strategy
without loss. A better understanding of digestion and reliable, re-
producible models that predict allergenicity are crucial. Especially key
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is determining i) why digestion abrogates, reduces, increases or does
not affect food protein allergenicity compared to the parent protein or
food, ii) why digestion products may retain IgE binding capacity but not
retain eliciting capacity and iii) why digestion products containing
small peptides may be allergenic. Research is necessary for addressing
the relevance of allergenicity assessment of products resulting from the
digestion process and recommendations are needed on the use of spe-
cific assays in assessment of IgE binding, eliciting and sensitising ca-
pacity.
12. Conclusion
The main conclusion of the meeting and the extensive literature
search that followed is that protein digestion is relevant for allergeni-
city of some proteins, but not for all. Many other factors in addition to
digestion in the stomach might play more pivotal roles and some of
these factors may have a great impact on digestion and should be in-
cluded in the digestion assay strategy. However, these factors compli-
cate the design and implementation of a simple, suitable and predictive
digestion assay/strategy enormously, especially because it is not clear
yet how these factors exactly influence digestion and how these factors
can be included. Moreover, there is no rationale on which to base a
clear readout that is predictive for allergenicity exclusively and the
exact route of exposure and mechanisms behind food sensitization and
food allergy are not fully understood yet. Therefore, we suggest to omit
the digestion test from the allergenicity assessment strategy for now
and put an effort into filling the knowledge gaps. Finally, any digestion
assay developed to support the allergenicity assessment of novel dietary
proteins should be validated and produce results that can distinguish
known allergens from non-allergens with a reasonable level of se-
lectivity.
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